The design of a clinical trial protocol typically has input from a small research team—rarely more than 10 reviewers and usually far fewer.
And the number of patients who review a protocol in detail and offer input is typically… zero.
Now, though, a different kind of clinical trial is about to begin enrolling patients, a trial that used crowdsourcing to develop the protocol. The trial will evaluate the use of metformin in men with rising prostate-specific antigen after localized treatment for prostate cancer.
Faster trial development and increased patient accrual are among the goals.
Link to the full article
This article was originally published in Oncology Times.
No comments:
Post a Comment